RecruitingNCT05156736

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults

Pakistan Study of Premature Coronary Atherosclerosis in Young Adults (PAK SEHAT)


Sponsor

Tabba Heart Institute

Enrollment

2,000 participants

Start Date

Mar 15, 2023

Study Type

OBSERVATIONAL

Conditions

Summary

Coronary heart disease (CHD) is a major cause of morbidity, disability, mortality, and health expenditures worldwide. A wealth of studies has demonstrated that people of South Asian ancestry have a higher risk of CHD and particularly premature CHD than most other racial/ethnic groups, and recent research suggests that this risk is higher in Pakistanis than in Indians-the two largest SA groups. Pakistan is the 5th most populous country in the world, and despite these concerning trends, so far there has been a scarcity of large studies evaluating the prevalence of cardiovascular risk factors and subclinical coronary atherosclerosis in young-to-middle-aged Pakistanis. Also, there is currently no cardiovascular risk score specifically tailored to younger Pakistani men and women. The PAKistan Study of prEmature coronary atHerosclerosis in young AdulTs (PAK-SEHAT) aims at addressing these important gaps. PAK-SEHAT is an ongoing prospective cohort study that will enroll 2,000 asymptomatic Pakistani men aged 35 to 60 years and women aged 35 to 65 years from the general population, free of clinically overt cardiovascular disease. Participants will undergo a comprehensive baseline exam including coronary computed tomography angiography, and will be followed for incident events and repeat testing for 5 years. PAK-SEHAT will allow determining the prevalence, severity, determinants, and prognostic significance of early atherosclerosis in apparently healthy young-to-middle-aged Pakistanis. This knowledge can help inform primordial and primary prevention strategies, enhanced cardiovascular risk stratification, and potential plaque-screening approaches in Pakistan, all of which can ultimately help reduce the burden of CHD in the country. In this report investigators describe the rationale, objectives, methods, and discuss the potential implications of the PAK-SEHAT study.


Eligibility

Min Age: 35 YearsMax Age: 65 Years

Plain Language Summary

Simplified for easier understanding

This study is investigating early-onset heart disease (coronary artery disease) in relatively young Pakistani adults. Researchers want to understand the risk factors that lead to heart artery blockages appearing earlier than expected in the Pakistani population. **You may be eligible if...** - You are a native Pakistani - Men aged 35–60 years, or women aged 35–65 years - You are willing to give your consent to participate **You may NOT be eligible if...** - Your kidneys are not working well (low kidney filtration rate) - You are pregnant - You have a history of stroke, heart attack, or heart bypass surgery - You have peripheral artery disease (poor circulation in the legs) - You weigh more than 102 kg - You have active cancer - You are allergic to contrast dye used in heart CT scans - You plan to move away from your residential area within 5 years Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Tabba Heart Institute

Karachi, Sindh, Pakistan

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05156736


Related Trials